Does age affect the prognosis of patients with testicular germ cell tumor?

Urologia Internationalis

Volumn 79, Issue 2, 2007, Pages 117-123

  Inci, Kubilay ^a   Dogan, Hasan Serkan ^a   Akdogan, Bulent ^a   Ergen, Ali ^a   Tasar, Celik ^a   Ozen, Haluk ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Age; Chemotherapy; Testicular cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; DISEASE SEVERITY; GERM CELL TUMOR; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; PROGNOSIS; SEMINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS; DATABASES; DISEASE PROGRESSION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; PROGNOSIS; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS;

EID: 34548638465     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106323     Document Type: Article

References (28)

1. dos Santos Silva I, Swerdlow AJ, Stiller CA, Reid A: Incidence of testicular germ-cell malignancies in England and Wales: trends in children compared with adults. Int J Cancer 1999;83:630-634.
2. Gilliland FD, Key CR: Male genital cancers. Cancer 1995;75:295-315.
3. Aareleid T, Sant M, Hedelin G: Improved survival for patients with testicular cancer in Europe since 1978. Eur J Cancer 1998;34:2236-2240.
4. Spermon JR, Witjes JA, Kiemeney LA: Difference in stage and morphology-adjusted survival between young and elderly patients with a testicular germ cell tumor. Urology 2002;60:889-893.
5. Mead GM, Stenning SP, Parkinson MC, Horwich A, Fossa SD, Wilkinson PM, Kaye SB, Newlands ES, Cook PA: The Second Medical Research Council study of prognostic factors in nonseminomatous germ cell tumors. Medical Research Council Testicular Tumour Working Party. J Clin Oncol 1992;10:85-94.
6. Balducci L, Extermann M: Management of cancer in the older person: a practical approach. Oncologist 2000;5:224-237.
7. Ozen H, Ekici S, Sozen S, Ergen A, Tekgul S, Kendi S: Resection of residual masses alone: an alternative in surgical therapy of metastatic testicular germ cell tumors after chemotherapy. Urology 2001;57:323-327.
8. Tekgul S, Ozen HA, Celebi I, Ozgu I, Ergen A, Demircin M, Remzi D: Postchemotherapeutic surgery for metastatic testicular germ cell tumors: results of extended primary chemotherapy and limited surgery. Urology 1994;43:349-354.
9. Halme A, Kellokumpu-Lehtinen P, Lehtonen T: Trends in incidence and results of treatment of testicular germ cell tumours in Finland 1972-1983. Acta Oncol 1989;28:777-783.
10. Balducci L: The geriatric cancer patient: equal benefit from equal treatment. Cancer Control 2001;8:1-25.
11. Hatton MQ, Paul J, Harding M, MacFarlane G, Robertson AG, Kaye SB: Changes in the incidence and mortality of testicular cancer in Scotland with particular reference to the outcome of older patients treated for non-seminomatous germ cell tumours. Eur J Cancer 1995;31:1487-1491.
12. Fentiman IS: Are the elderly receiving appropriate treatment for cancer? Ann Oncol 1996;7:657-658.
13. Yancik R, Havlik RJ, Wesley MN, Ries L, Long S, Rossi WK, Edwards BK: Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 1996;6:399-412.
14. Ganz PA: Does (or should) chronologic age influence the choice of cancer treatment? Oncology (Huntingt) 1992;6:45-49.
15. Balducci L, Corcoran MB: Antineoplastic chemotherapy of the older cancer patient. Hematol Oncol Clin North Am 2000;14:193-212.
16. Duthie E: Physiology of aging: relevance to symptom perception and treatment tolerance; in Balducci L, Lyman GH, Ershler WB (eds): Comprehensive Geriatric Oncology. London, Harward Academic Publishers, 1998, pp 247-262.
17. McKenna RJ Sr: Clinical aspects of cancer in the elderly. Treatment decisions, treatment choices, and follow-up. Cancer 1994;74:2107-2117.
18. Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW: The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 1976;31:155-163.
19. Kintzel PE, Dorr RT: Anticancer drug renal toxicity and elimination: dosing guidelines for altered renal function. Cancer Treat Rev 1995;21:33-64.
20. Thyss A, Saudes L, Otto J, Creisson A, Gaspard MH, Dassonville O, Schneider M: Renal tolerance of cisplatin in patients more than 80 years old. J Clin Oncol 1994;12:2121-2125.
21. Cohen HJ: Geriatric principles of treatment applied to medical oncology: an overview. Semin Oncol 1995;22:1-2.
22. Counsell R, Pratt J, Williams MV: Chemotherapy for germ cell tumours: prophylactic ciprofloxacin reduces the incidence of neutropenic fever. Clin Oncol (R Coll Radiol) 1994;6:232-236.
23. Dearnaley DP, Horwich A, A'Hern R, Nicholls J, Jay G, Hendry WF, Peckham MJ: Combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for metastatic testicular teratoma: long-term follow-up. Eur J Cancer 1991;27:684-691.
24. O'Sullivan JM, Huddart RA, Norman AR, Nicholls J, Dearnaley DP, Horwich A: Predicting the risk of bleomycin lung toxicity in patients with germ-cell tumours. Ann Oncol 2003;14:91-96.
25. Balducci L, Mowry K: Pharmacology and organ toxicity of chemotherapy in older patients. Oncology (Huntingt) 1992;6:62-68.
26. Goodwin JS, Samet JM, Hunt WC: Determinants of survival in older cancer patients. J Natl Cancer Inst 1996;88:1031-1038.
27. Okuno J, Yanagi H, Tomura S: Is cognitive impairment a risk factor for poor compliance among Japanese elderly in the community? Eur J Clin Pharmacol 2001;57:589-594.
28. Hernes EH, Harstad K, Fossa SD: Changing incidence and delay of testicular cancer in southern Norway (1981-1992). Eur Urol 1996;30:349-357.